Biliary tract cancer

Current Opinion in Gastroenterology

Volumn 14, Issue 5, 1998, Pages 402-407

  Josephs, Michael D ^a   Vauthey, Jean Nicolas ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FLUOROURACIL; METAL; MITOMYCIN; PROTEIN BCL 2; PROTEIN P53; TAMOXIFEN;

APOPTOSIS; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILIARY TRACT CANCER; BILIARY TRACT DRAINAGE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOGENESIS; CHOLECYSTECTOMY; DIAGNOSTIC IMAGING; ECHOGRAPHY; ENDOSCOPY; GALLBLADDER CARCINOMA; GALLBLADDER MUCOSA; GENE THERAPY; HIGH RISK PATIENT; HUMAN; INTESTINE POLYP; INTRAHEPATIC BILE DUCT; INVASIVE CARCINOMA; LIVER RESECTION; MOLECULAR BIOLOGY; NONHUMAN; PEROPERATIVE ECHOGRAPHY; PREOPERATIVE EVALUATION; PROTEIN EXPRESSION; QUALITY OF LIFE; REVIEW; STENT; TUMOR VOLUME; VASCULAR SURGERY;

EID: 0031720167     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199809000-00009     Document Type: Review

References (43)

1. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1998. CA Cancer J Clin 1998, 48:6-29.
2. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, et al.: Mutations in the p53 gene occur in diverse human tumour types. Nature 1989, 342:705-708.
3. Diamantis I, Karamitopoulou E, Perentes E, Zimmermann A: p53 Immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Hepatology 1995, 22:774-779.
4. Itoi T, Watanabe H, Yoshida M, Ajioka Y, Nishikura K, Saito T: Correlation of p53 protein expression with gene mutation in gall-bladder carcinomas. Pathol Int 1997, 47:525-530.
5. Harnois DM, Que FG, Celli A, LaRusso NF, Gores GJ: Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line. Hepatology 1997, 26:884-890. Provides a novel hypothesis as to the molecular mechanisms underlying biliary tract carcinogenesis.
6. Nishida T, Iwasaki H, Johzaki H, Tanaka S, Watanabe R, Kikuchi M: A human gall-bladder signet ring cell carcinoma cell line. Pathol Int 1997, 47:368-376.
7. Espat NJ, Vauthey JN: Biliary tract cancer. Curr Opin Gastroenterol 1997, 13:410-415.
8. Cendan JC, Zlotecki RA, Vauthey JN: Biliary tract cancer. Curr Opin Gastroenterol 1996, 12:460-465.
9. Vauthey JN, Blumgart LH: Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 1994, 14:109-114.
10. Hann LE, Greatrex KV, Bach AM, Fong Y, Blumgart LH: Cholangiocarcinoma at the hepatic hilus: sonographic findings. AJR Am J Radiol 1997, 168:985-989. The tumor mass, the level and type of obstruction, and the involvement of the portal vein can be accurately demonstrated by ultrasonography.
11. Tomiyama T, Ueno N, Tano S, Wada S, Miyata T, Kimura K: Assessment of right hepatic artery involvement in patients with biliary tract cancer using color doppler ultrasonography. J Clin Ultrasound 1997, 25:317-323.
12. Sugiyama M, Hagi H, Atomi Y, Saito M: Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography. Abdom Imaging 1997, 22:434-438.
13. Duda SH, Huppert PE, Schott U, Brambs H-J, Claussen CD: Percutaneous transhepatic intraductal biliary sonography for lymph node staging at 12.5 MHz in malignant bile duct obstruction: work in progress. Cardiovasc Intervent Radiol 1997, 20:133-138.
14. Kusano T, Shimabukuro M, Tamai O, Miyazato H, Shiraishi M, Yamada M, Muto Y: The use of intraoperative ultrasonography for detecting tumor extension in bile duct carcinoma. Int Surg 1997, 82:44-48.
15. Mansfield JC, Griffin SM, Wadehra V, Matthewson K: A prospective evaluation of cytology from biliary strictures. Gut 1997, 40:671-677.
16. Ritchie JK, Allan RN, Macartney J, Thompson H, Hawley PR, Cooke WT: Biliary tract carcinoma associated with ulcerative colitis. Q J Med 1974, 43:263-279.
17. Suda K, Miyano T, Konuma I, Matsumoto M: An abnormal pancreaticocholedocho-ductal junction in cases of biliary tract carcinoma. Cancer 1983, 52:2086-2089.
18. Nagomey D: Choledochal cysts in adult life. In Liver and Biliary Tract. Edited by Blumgart LH. Edinburgh: Churchill Livingstone; 1988:1003-1012.
19. Rosen CB, Nagorney DM: Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis 1991, 11:26-30.
20. Sher L, Iwatsuki S, Lebeau G, Zajko AB: Hilar cholangiocarcinoma associated with clonorchiasis. Dig Dis Sci 1989, 34:1121-1123.
21. Hakamada K, Sasaki M, Endoh M, Itoh T, Morita T, Konn M: Late development of bile duct cancer after sphincteroplasty: a ten-to twenty-two-year follow-up study. Surgery 1997, 121:488-492. The authors point to a new causative factor of bile duct cancer.
22. Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr R: Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 1997, 15:947-954. Resection of central bile duct carcinoma is feasible in many patients. Curative resection and the absence of lymph node metastases are the main determinants of a favorable outcome.
23. Rieber A, Brambs H-J: Metallic stents in malignant biliary obstruction. Cardiovasc Intervent Radiol 1997, 20:43-49.
24. Schima W, Prokesch R, Osterreicher C, Thurnher S, Függer R, Schöfl R, Havelec L, Lammer J: Biliary wallstent endoprosthesis in malignant hilar obstruction: long-term results with regard to the type of obstruction. Clin Radiol 1997, 52:213-219.
25. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH: The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948, 1:634-656.
26. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5:649-655.
27. Bismuth H, Castaing D, Traynor O: Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg 1988, 12:39-47.
28. Luman W, Cull A, Palmer KR: Quality of life in patients stented for malignant biliary obstructions. Eur J Gastroenterol Hepatol 1997, 9:481-484.
29. Bowling TE, Galbraith SM, Hatfield ARW, Solano J, Spittle MF: A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut 1996, 39:852-855.
30. Leung JT, Kuan R: Intraluminal brachytherapy in the treatment of bile duct carcinomas. Australas Radiol 1997, 41:151-154.
31. Harvey JH, Smith FP, Schein PS: 5-Fluorouracil, mitomycin, and doxorubicin (fam) in carcinoma of the biliary tract. J Clin Oncol 1984, 2:1245-1248.
32. Sampson LK, Vickers SM, Ying W, Phillips JO: Tamoxifen-mediated growth inhibition of human cholangiocarcinoma. Cancer Res 1997, 57:1743-1749.
33. Pederson LC, Buchsbaum DJ, Vickers SM, Kancharla SR, Mayo MS, Curiel DT, Stackhouse MA: Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Cancer Res 1997, 57:4325-4332. This experimental study suggests in vitro and in vivo methods for integrating molecular chemotherapy strategies with radiation therapy for the treatment of cholangiocarcinoma.
34. Yamaguchi K, Chijiiwa K, Saiki S, Nishihara K, Takashima M, Kawakami K, Tanaka M: Retrospective analysis of 70 operations for gallbladder carcinoma. Br J Surg 1997, 84:200-204. Radical resection including lymph node dissection is justified in pT2 gallbladder carcinoma.
35. Beltz WR, Condon RE: Primary carcinoma of the gallbladder. Ann Surg 1974, 180:180-184.
36. Lowenfels AB, Lindstrom CG, Conway MJ, Hastings PR: Gallstones and risk of gallbladder cancer. J Natl Cancer Inst 1985, 75:77-80.
37. Redaelli CA, Büchler MW, Schilling MK, Krähenbühl L, Ruchti C, Blumgart LH, Baer HU: High coincidence of Mirizzi syndrome and gallbladder carcinoma. Surgery 1997, 121:58-63.
38. Aldridge MC, Bismuth H: Gallbladder cancer: the polyp-cancer sequence. Br J Surg 1990, 77:363-364.
39. Moriguchi H, Tazawa J, Hayashi Y, Takenawa H, Nakayama E, Marumo F, Sato C: Natural history of polypoid lesions in the gall bladder. Gut 1996, 39:860-862.
40. Koga A, Watanabe K, Fukuyama T, Takigushi S, Nakayama F: Diagnosis and operative indications for polypoid lesions of the gallbladder. Arch Surg 1988, 123:26-29.
41. Yang HL, Sun YG, Wang Z. Polypoid lesions of the gallbladder: diagnosis and indications for surgery. Br J Surg 1992, 79:227-229.
42. Boulton RA, Adams DH: Gallbladder polyps: when to wait and when to act. Lancet 1997, 349:817. Provides a concise review and a useful algorithm for the management of gallbladder polyps.
43. Shimada H, Endo I, Togo S, Nakano A, Izumi T, Nakagawara G: The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer 1997, 79:892-899.